82 related articles for article (PubMed ID: 6995285)
21. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
[TBL] [Abstract][Full Text] [Related]
22. The growth advantage in stationary-phase (GASP) phenomenon in mixed cultures of enterobacteria.
Bacun-Druzina V; Cagalj Z; Gjuracic K
FEMS Microbiol Lett; 2007 Jan; 266(1):119-27. PubMed ID: 17233722
[TBL] [Abstract][Full Text] [Related]
23. Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.
Inoue S; Ohue T; Yamagishi J; Nakamura S; Shimizu M
Antimicrob Agents Chemother; 1978 Aug; 14(2):240-5. PubMed ID: 358918
[TBL] [Abstract][Full Text] [Related]
24. [Effect of the action of nalidixic acid on the submicroscoic structure of bacteria].
Kats LN; Andreeva AM; Moroz AF
Antibiotiki; 1968 Sep; 13(9):841-5. PubMed ID: 4884476
[No Abstract] [Full Text] [Related]
25. An unusual interaction between the target of nalidixic acid and novobiocin.
Chao L
Nature; 1978 Jan; 271(5643):385-6. PubMed ID: 340962
[No Abstract] [Full Text] [Related]
26. Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones.
Medders WM; Wooley RE; Gibbs PS; Shotts EB; Brown J
Avian Dis; 1998; 42(1):146-53. PubMed ID: 9533092
[TBL] [Abstract][Full Text] [Related]
27. Fluctuation analysis of mutations to nalidixic acid resistance in Escherichia coli.
Boe L; Tolker-Nielsen T; Eegholm KM; Spliid H; Vrang A
J Bacteriol; 1994 May; 176(10):2781-7. PubMed ID: 8188580
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
Lautenbach E; Fishman NO; Metlay JP; Mao X; Bilker WB; Tolomeo P; Nachamkin I
J Infect Dis; 2006 Jul; 194(1):79-85. PubMed ID: 16741885
[TBL] [Abstract][Full Text] [Related]
29. Proteomic analysis of nalidixic acid resistance in Escherichia coli: identification and functional characterization of OM proteins.
Lin XM; Li H; Wang C; Peng XX
J Proteome Res; 2008 Jun; 7(6):2399-405. PubMed ID: 18438992
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of nalidixic acid on Escherichia coli. V. Possible mutagenic effect.
Cook TM; Goss WA; Deitz WH
Acta Chir Belg; 1966; ():780-3. PubMed ID: 5327371
[No Abstract] [Full Text] [Related]
31. [Effect of R-factor on E.coli sensitivity to ultraviolet and -radiation].
Gromova TG; Moraz AF
Antibiotiki; 1971 Nov; 16(11):995-8. PubMed ID: 4947973
[No Abstract] [Full Text] [Related]
32. [Quinolone resistance in Salmonella enterica].
Seral C; López L; Castillo FJ; Clavel A; Rubio MC
Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
[TBL] [Abstract][Full Text] [Related]
33. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
[TBL] [Abstract][Full Text] [Related]
34. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
Mammeri H; Van De Loo M; Poirel L; Martinez-Martinez L; Nordmann P
Antimicrob Agents Chemother; 2005 Jan; 49(1):71-6. PubMed ID: 15616277
[TBL] [Abstract][Full Text] [Related]
35. [Effect of some antitumor chemotherapeutic preparations on the transfer of the episome determinant of resistance in enterobacterial].
Smolianskaia AZ
Mikrobiologiia; 1970; 39(5):882-6. PubMed ID: 4925039
[No Abstract] [Full Text] [Related]
36. The responses of Escherichia coli to nalidixic acid.
Greenwood D; O'Grady F
Chemotherapy; 1978; 24(4):249-58. PubMed ID: 348417
[No Abstract] [Full Text] [Related]
37. Clonal expansion may account for high levels of quinolone resistance in Salmonella enterica serovar enteritidis.
Kilmartin D; Morris D; O'Hare C; Corbett-Feeney G; Cormican M
Appl Environ Microbiol; 2005 May; 71(5):2587-91. PubMed ID: 15870349
[TBL] [Abstract][Full Text] [Related]
38. Nalidixic acid-resistant salmonellae.
Wray C; McLaren I; Wise R; Piddock LJ
Vet Rec; 1990 May; 126(19):489. PubMed ID: 2349770
[No Abstract] [Full Text] [Related]
39. Evaluation of a survey approach to estimating the prevalence of cattle carrying antimicrobial-resistant Escherichia coli.
Gunn GJ; Hall M; Hunter EA; Low JC
Vet J; 2008 Mar; 175(3):416-8. PubMed ID: 17448712
[TBL] [Abstract][Full Text] [Related]
40. New hemolysin (gamma) produced by Escherichia coli.
Walton JR; Smith DH
J Bacteriol; 1969 Apr; 98(1):304-5. PubMed ID: 4891808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
